PAHC
Phibro Animal Health Corp
Price:  
18.15 
USD
Volume:  
94,405.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

PAHC EV/EBITDA

-8.3%
Upside

As of 2024-05-30, the EV/EBITDA ratio of Phibro Animal Health Corp (PAHC) is 11.82. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. PAHC's latest enterprise value is 1,170.67 mil USD. PAHC's TTM EBITDA according to its financial statements is 99.04 mil USD. Dividing these 2 quantities gives us the above PAHC EV/EBITDA ratio.

Range Selected
Trailing P/E multiples 9.3x - 10.8x 9.9x
Forward P/E multiples 10.4x - 11.7x 11.0x
Fair Price 12.09 - 21.72 16.64
Upside -33.4% - 19.7% -8.3%
18.15 USD
Stock Price
16.64 USD
Fair Price

PAHC EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2024-05-30 11.68
2024-05-29 11.82
2024-05-28 11.77
2024-05-24 11.98
2024-05-23 11.95
2024-05-22 11.93
2024-05-21 11.91
2024-05-20 11.85
2024-05-17 11.92
2024-05-16 11.75
2024-05-15 11.86
2024-05-14 11.84
2024-05-13 11.80
2024-05-10 11.57
2024-05-09 11.64
2024-05-08 11.42
2024-05-07 11.26
2024-05-06 11.12
2024-05-03 11.38
2024-05-02 11.25
2024-05-01 11.08
2024-04-30 11.23
2024-04-29 11.26
2024-04-26 9.60
2024-04-25 9.48
2024-04-24 9.53
2024-04-23 9.96
2024-04-22 9.73
2024-04-19 9.84
2024-04-18 9.73
2024-04-17 9.66
2024-04-16 9.71
2024-04-15 9.80
2024-04-12 9.76
2024-04-11 9.75
2024-04-10 9.81
2024-04-09 9.76
2024-04-08 9.66
2024-04-05 9.64
2024-04-04 9.67
2024-04-03 9.69
2024-04-02 9.54
2024-04-01 9.55
2024-03-28 9.69
2024-03-27 9.74
2024-03-26 9.65
2024-03-25 9.53
2024-03-22 9.34
2024-03-21 9.42
2024-03-20 9.49